The origins and neural bases of the current opioid addiction epidemic are unclear. Genetics plays a major role in addiction vulnerability, but cannot account for the recent exponential rise in opioid abuse, so environmental factors must contribute. Individuals with history of early-life adversity (ELA) are disproportionately prone to opioid addiction, yet whether ELA directly influences brain development and function to cause this vulnerability is unknown. We simulated ELA in female rats, which provoked a profound opioid-addiction vulnerability. This was characterized by resistance to extinction, increased relapse-like behavior, and, as in addicted humans, major increases in opioid economic demand. By contrast, seeking of less salient natural rewards was unaffected by ELA, whereas demand for highly palatable treats was augmented. These discoveries provide novel insights into the origins and nature of reward circuit malfunction that may set the stage for addiction.
The Limited Bedding and Nesting (LBN) model of early-life adversityOn PD2, pups from at least two litters were gathered, and pups were assigned at random to each dam in equal numbers of male and female to prevent potential confounding effect of genetic variables or litter size. Dams and pups assigned to the LBN group were transferred to cages fitted with a plastic-coated mesh platform sitting ∼ 2.5 cm above the cage floor. Bedding sparsely covered the cage floor under the platform, and one-half of a 24.2 cm × 23.5 cm paper towel was provided for nesting material. Control group (CTL) dams and pups were placed in cages containing a standard amount of bedding (∼0.33 cubic feet of shredded corn cob) without a platform, and one full paper towel. CTL and LBN cages remained undisturbed during PD2-9, during which maternal behaviors were monitored as previously described 12-14 . On PD10, animals were all transferred to CTL condition cages.
Intravenous catheter surgeryAt approximately PD70, rats were deeply anesthetized with isoflurane (2-2.5%) and chronic indwelling catheters were inserted into the right jugular vein, exiting two cm caudal to the scapulae. Meloxicam (1mg/kg, i.p.) for postsurgical analgesia, and prophylactic antibiotic cefazolin (0.2ml, i.v.; 10mg/0.1ml) were given perioperatively. After 5 days of recovery, catheters were flushed daily following each opioid self-administration session with cefazolin (10mg/0.1ml) and heparin lock solution (10 U/0.1ml) to maintain catheter patency.